The IARS recently announced the appointment of Lena S. Sun, MD, as the Medical Director of SmartTots. Dr. Sun is an established basic science, translational and clinical researcher, a board-certified physician in Pediatrics, Anesthesiology and Pediatric Anesthesiology and a practicing pediatric anesthesiologist. As the Medical Director of SmartTots, she will help promote and advocate for research to advance and ensure safety of anesthesia in children. She will specifically work with researchers, clinicians, parents and other relevant stakeholders to develop future research strategies to address the pressing challenges to understand the effects of anesthetic and sedative agents in the developing brain. She will also work with all stakeholders to support the implementation and dissemination of research results related to all SmartTots-related issues.
- Sevoflurane-induced learning deficits and spine loss via nectin-1/corticotrophin-releasing hormone receptor type 1 signalling in neonatal mice
- Effects of non-obstetric surgery under ketamine anaesthesia in the middle stage of pregnancy on cognition in the offspring and underlying mechanisms
- Female rats are more vulnerable to lasting cognitive impairment after isoflurane exposure on postnatal day 4 than 7
- Dexmedetomidine attenuates the neurotoxicity of propofol toward primary hippocampal neurons in vitro via Erk1/2/CREB/BDNF signaling pathways
- Effects of Perinatal Exposure to Ketamine on the Developing Brain